Drug Trial Radar · NCT06752356
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
161
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Dec 20, 2027
Study completion Dec 27, 2027
Sponsor
- Lead sponsor
- Kedrion S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Dec 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The current study is being conducted to assess the efficacy and safety of KIg10 (Intravenous Human Immune globulin 10%) at two different dosages as maintenance therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) following 21 weeks of treatment.
Conditions
- Chronic Inflammatory Demyelinating Polyneuropathy
Interventions
Immune globulin (human) 10% solution for intravenous administrationBiological
Kedrion intravenous immunoglobulin (IVIg) 10%
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of 1.0 g/kg KIg10 in the treatment of adult subjects with active CIDPTime frame: From Baseline upto 24 weeks of treatment
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
New England Institute for Clinical Research
Stamford, Connecticut · Recruiting
Quantix Research
Miami, Florida · Recruiting
Best Choice Medical and Research Service
Pembroke Pines, Florida · Recruiting
USF Health - Morsani Center for Advanced Healthcare
Tampa, Florida · Recruiting
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire · Recruiting
Advanced Neurology Epilepsy and Sleep Center/ANESC Research
El Paso, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.